While the guidelines are clear about the need to treat tuberculosis in the setting HIV infection, the reality is that many patients with HIV/TB co-infection Read More
No abstract available
Stigma is a known barrier to HIV testing and care.
Science: Large study spotlights limits of HIV treatment as prevention “One of the great unknowns in HIV/AIDS research is how much prevention bang you get for your treatment buck. Yes, antiretroviral (ARV) drugs make individuals less infectious, but how many people have to be on treatment to slow spread in a community and even bring…More
Categories: AIDS2016DURBAN, South Africa – Today’s plenary session today saw a new 90-90-90 goal set in a talk on tuberculosis and viral hepatitis today: $90 for HIV treatment, $90 for hepatitis B treatment and $90 for hepatitis C cure. Dr.Anton Pozniak, the director of HIV services at Chelsea and Westminster Hospital NHS Trust in London, issued the challenge. The hepatitis […](Read more…)
Categories: AIDS2016“No human being should be left behind” Sir Elton John DURBAN, South Africa – The International AIDS Alliance and the Global Forum on MSM & HIV will receive the first grants under a j$10 million fund launched by the Elton John AIDS Foundation and the President’s Emergency Plan for AIDS Relief to open and ensure access to […](Read more…)
Categories: AIDS2016DURBAN, South Africa – Global funding for HIV responses has declined in real numbers and in impact potential for the first time in five years, researchers and advocates told reporters here Tuesday, injecting reality into an ambition focused conference. The 13 percent drop in international donor funding from 2014 to 2015 means less money for effective responses […](Read more…)
Editors note: As part of our coverage of the 21st International AIDS Conference, we are reposting part one of a series from the Seattle Times about the Fred Hutchinson Cancer Research Center’s effort to find an effective HIV vaccine. View the full report here. By Nina Shapiro, Seattle Times staff reporter CAPE TOWN, South Africa
Seattle Medium: Show Me The Money: Global HIV/AIDS Funding On The Decline “Throughout AIDS 2016, whispers that global funds to fight HIV/AIDS have begun to dry up have turned to shouts. … Donor government funding to support HIV efforts in low- and middle-income countries fell for the first time in five years in 2015, according…More
Categories: AIDS2016Antiretroviral therapy impact is huge, but gender disparities drive differences in death rates DURBAN, South Africa – Globally adult life expectancy gained from 10-14 years over a decade following access to HIV treatment, the greatest life expectancy gains recorded in modern history, according to researchers from the London School of Hygiene and Tropical Medicine. Greater life expectancy gains were seen […](Read more…)
Background: HIV-related stigma is associated with increased risk-taking behavior, reduced uptake of HIV testing, and decreased adherence to antiretroviral therapy (ART).
Categories: AIDS2016“AIDS exposes us in all our human vulnerabilities . . .” Justice Edwin Cameron, July 19, 2016 DURBAN, South Africa – Justice Edwin Cameron concluded his talk at the first morning session of this conference with an invitation to sex workers in the audience to “take over the stage.” Dr. Sunil Sunhas Solomon concluded his with a pledge to carry on the […](Read more…)
Bad quality data on HIV results in poor care for women and marginalised groups, a report finds.
Objective: Combination antiretroviral therapy (ART) decreases the risk of sexual HIV transmission by suppressing blood and genital HIV RNA concentrations.
Background: Tuberculosis (TB) risk and mortality increase in the 6 months after highly active antiretroviral therapy (HAART) initiation.
Introduction: Treatment as prevention relies on early uptake of HIV treatment, but onward transmission during primary HIV infection may be affected by changes in sexual risk behavior after diagnosis.